Restless Legs Syndrome Foundation Blog

Anticipates Product in Pharmacies in Early June SANTA CLARA, Calif.--(BUSINESS WIRE)-- XenoPort, Inc. (Nasdaq: XNPT) announced today that shipments of Horizant® (gabapentin enacarbil) Extended-Release Tablets to its distributor in the United States have commenced. Depending on individual pharmacy ordering patterns, the product is anticipated to be generally available to patients in the first week of June. “We are...

Read More

Flying High with WED/RLS Let me begin by saying, I love to travel.  Last year, my husband, our then-13-year-old granddaughter, and I were fortunate enough to realize a dream:  a trip to South Africa!  Safaris and scenery unlike anything we had ever experienced; friendly, fellow travellers and personable, informative tour guides; awesome photo opportunities and a foreign currency...

Read More

A big thank you to  Dr. Buchfuhrer for his wonderful presentation on working with your healthcare provider.  The recording of this Webinar is no longer available. Please contact us at info@willis-ekbom.org about viewing the webinar. You can view the PowerPoint here.  ...

Read More

A shortage of Horizant continues to impact the WED/RLS community. A medication approved by the FDA in 2011 to treat WED/RLS symptoms, Horizant (gabapentin enacarbil) has been in short supply since April due to manufacturing delays. Drug developer XenoPort Inc. said it hopes a new stock of Horizant will be in pharmacies in June, but the timing is...

Read More

In about 1998, my eight-year-old granddaughter and I were camping in New Hampshire. It was cold and rainy, so we spent quite a bit of the time huddled in our pop-up camper. I just wanted to bundle up in my sleeping bag and take a nap. But there was no rest for me! My granddaughter said, “I’m sorry,...

Read More